CohBar, Inc.’s CEO Simon Allen to Present at the 9th Annual Biotech Showcase in San Francisco Jan 10, 2017
CohBar, Inc. Continues Exploration of Mitochondrial Genome and Expansion of Its IP Portfolio with Filing of 29 New Provisional Patents Dec 6, 2016
CohBar Advances First-in-Class Mitochondria Based Therapeutic to IND-Enabling Activities Sep 30, 2016
CohBar, Inc. Announces Preclinical Proof-of-principle Publication for SHLP Mitochondrial-derived Peptides and their Role in Metabolic Regulation and Cell Viability Apr 11, 2016
